Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Total Assets of $96.39 million for fiscal year 2025.
ELITE PHARMACEUTICALS INC /NV/ Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $96.39M | +15.2% |
| 2024 | $83.65M | +104.6% |
| 2023 | $40.90M | +16.4% |
| 2022 | $35.15M | +34.2% |
| 2021 | $26.19M | +4.9% |
| 2020 | $24.96M | +2.3% |
| 2019 | $24.40M | -21.0% |
| 2018 | $30.88M | -10.0% |
| 2017 | $34.31M | +8.3% |
| 2016 | $31.67M | +22.2% |
| 2015 | $25.92M | +6.6% |
| 2014 | $24.32M | +118.6% |
| 2013 | $11.13M | +7.9% |
| 2012 | $10.31M | -12.5% |
| 2011 | $11.79M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $126.41M | +39.3% | +7.8% |
| September 30, 2025 | $117.25M | +32.9% | +5.3% |
| June 30, 2025 | $111.34M | +26.7% | +15.5% |
| March 31, 2025 | $96.39M | +15.2% | +6.2% |
| December 31, 2024 | $90.76M | +21.5% | +2.9% |
| September 30, 2024 | $88.20M | +24.7% | +0.4% |
| June 30, 2024 | $87.85M | +88.9% | +5.0% |
| March 31, 2024 | $83.65M | +104.6% | +12.0% |
- ELITE PHARMACEUTICALS INC /NV/ showed an increase of +15.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ELITE PHARMACEUTICALS INC /NV/’s total assets has grown by 717.7% (from $11.79 million to $96.39 million).
- The most recent figure is from ELITE PHARMACEUTICALS INC /NV/’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: